ABBV Financial Statements

Balance sheet, income statement, cash flow, and dividends for Abbvie Inc (ABBV).


$314.02B Market Cap.

As of 02/14/2025 5:00 PM ET (MRY) • Disclaimer

ABBV Market Cap. (MRY)


ABBV Shares Outstanding (MRY)


ABBV Assets (MRY)


Total Assets

$135.16B

Total Liabilities

$131.80B

Total Investments

$310.00M

ABBV Income (MRY)


Revenue

$56.33B

Net Income

$4.28B

Operating Expense

$30.29B

ABBV Cash Flow (MRY)


CF Operations

$18.81B

CF Investing

-$20.82B

CF Financing

-$5.21B

ABBV Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$6.20

3.50%

4.73%

258.33%

0.39

2023

$5.92

3.80%

4.96%

216.85%

0.46

2022

$5.64

3.50%

8.46%

84.81%

1.18

2021

$5.20

3.80%

10.17%

80.25%

1.25

2020

$4.72

4.40%

-

172.89%

0.58

ABBV Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$135,161,000,000 (0.33%)

$134,711,000,000 (-2.95%)

$138,805,000,000 (-5.27%)

$146,529,000,000 (-2.68%)

Assets Current

$25,582,000,000 (-22.48%)

$33,002,000,000 (15.95%)

$28,463,000,000 (1.92%)

$27,928,000,000 (15.53%)

Assets Non-Current

$109,579,000,000 (7.74%)

$101,709,000,000 (-7.82%)

$110,342,000,000 (-6.96%)

$118,601,000,000 (-6.16%)

Goodwill & Intangible Assets

$95,024,000,000 (8.10%)

$87,903,000,000 (-11.74%)

$99,595,000,000 (-8.06%)

$108,330,000,000 (-6.61%)

Shareholders Equity

$3,325,000,000 (-67.91%)

$10,360,000,000 (-39.96%)

$17,254,000,000 (11.98%)

$15,408,000,000 (17.83%)

Property Plant & Equipment Net

$5,134,000,000 (2.91%)

$4,989,000,000 (1.09%)

$4,935,000,000 (-3.42%)

$5,110,000,000 (-2.63%)

Cash & Equivalents

$5,524,000,000 (-56.89%)

$12,814,000,000 (39.27%)

$9,201,000,000 (-5.59%)

$9,746,000,000 (15.35%)

Accumulated Other Comprehensive Income

-$1,925,000,000 (16.49%)

-$2,305,000,000 (-4.82%)

-$2,199,000,000 (24.15%)

-$2,899,000,000 (6.99%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$310,000,000 (1.31%)

$306,000,000 (13.75%)

$269,000,000 (-25.48%)

$361,000,000 (11.76%)

Investments Current

$31,000,000 (1450.00%)

$2,000,000 (-92.86%)

$28,000,000 (-66.67%)

$84,000,000 (180.00%)

Investments Non-Current

$279,000,000 (-8.22%)

$304,000,000 (26.14%)

$241,000,000 (-13.00%)

$277,000,000 (-5.46%)

Inventory

$4,181,000,000 (2.00%)

$4,099,000,000 (14.53%)

$3,579,000,000 (14.42%)

$3,128,000,000 (-5.50%)

Trade & Non-Trade Receivables

$10,919,000,000 (-2.12%)

$11,155,000,000 (-0.88%)

$11,254,000,000 (12.80%)

$9,977,000,000 (13.09%)

Trade & Non-Trade Payables

$31,945,000,000 (4.23%)

$30,650,000,000 (20.66%)

$25,402,000,000 (11.91%)

$22,699,000,000 (12.60%)

Accumulated Retained Earnings (Deficit)

-$7,900,000,000 (-690.00%)

-$1,000,000,000 (-120.90%)

$4,784,000,000 (52.99%)

$3,127,000,000 (196.40%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$2,579,000,000 (32.12%)

$1,952,000,000 (-10.87%)

$2,190,000,000 (-27.22%)

$3,009,000,000 (-17.47%)

Total Debt

$67,144,000,000 (13.07%)

$59,385,000,000 (-6.14%)

$63,271,000,000 (-17.49%)

$76,684,000,000 (-10.89%)

Debt Current

$6,804,000,000 (-5.38%)

$7,191,000,000 (73.86%)

$4,136,000,000 (-66.90%)

$12,495,000,000 (46.97%)

Debt Non-Current

$60,340,000,000 (15.61%)

$52,194,000,000 (-11.74%)

$59,135,000,000 (-7.87%)

$64,189,000,000 (-17.23%)

Total Liabilities

$131,797,000,000 (6.02%)

$124,314,000,000 (2.30%)

$121,518,000,000 (-7.30%)

$131,093,000,000 (-4.64%)

Liabilities Current

$38,749,000,000 (2.40%)

$37,841,000,000 (28.11%)

$29,538,000,000 (-16.07%)

$35,194,000,000 (22.79%)

Liabilities Non-Current

$93,048,000,000 (7.60%)

$86,473,000,000 (-5.99%)

$91,980,000,000 (-4.09%)

$95,899,000,000 (-11.86%)

ABBV Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$56,334,000,000 (3.71%)

$54,318,000,000 (-6.44%)

$58,054,000,000 (3.30%)

$56,197,000,000 (22.69%)

Cost of Revenue

$16,904,000,000 (-17.20%)

$20,415,000,000 (17.23%)

$17,414,000,000 (-0.18%)

$17,446,000,000 (13.38%)

Selling General & Administrative Expense

$14,752,000,000 (14.61%)

$12,872,000,000 (-15.65%)

$15,260,000,000 (23.57%)

$12,349,000,000 (9.29%)

Research & Development Expense

$12,791,000,000 (66.66%)

$7,675,000,000 (17.90%)

$6,510,000,000 (-5.95%)

$6,922,000,000 (8.51%)

Operating Expenses

$30,293,000,000 (43.26%)

$21,146,000,000 (-6.11%)

$22,523,000,000 (8.14%)

$20,827,000,000 (9.31%)

Interest Expense

$2,160,000,000 (28.27%)

$1,684,000,000 (-17.61%)

$2,044,000,000 (-14.26%)

$2,384,000,000 (4.56%)

Income Tax Expense

-$570,000,000 (-141.39%)

$1,377,000,000 (-15.63%)

$1,632,000,000 (13.33%)

$1,440,000,000 (217.65%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

$4,286,000,000 (-12.05%)

$4,873,000,000 (-58.86%)

$11,845,000,000 (2.56%)

$11,549,000,000 (149.87%)

Net Income to Non-Controlling Interests

$8,000,000 (-20.00%)

$10,000,000 (11.11%)

$9,000,000 (28.57%)

$7,000,000 (16.67%)

Net Income

$4,278,000,000 (-12.03%)

$4,863,000,000 (-58.91%)

$11,836,000,000 (2.55%)

$11,542,000,000 (150.04%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

$4,278,000,000 (-12.03%)

$4,863,000,000 (-58.91%)

$11,836,000,000 (2.55%)

$11,542,000,000 (150.04%)

Weighted Average Shares

$1,769,000,000 (0.06%)

$1,768,000,000 (-0.17%)

$1,771,000,000 (0.06%)

$1,770,000,000 (6.18%)

Weighted Average Shares Diluted

$1,773,000,000 (0.00%)

$1,773,000,000 (-0.28%)

$1,778,000,000 (0.06%)

$1,777,000,000 (6.22%)

Earning Before Interest & Taxes (EBIT)

$5,868,000,000 (-25.95%)

$7,924,000,000 (-48.92%)

$15,512,000,000 (0.95%)

$15,366,000,000 (170.91%)

Gross Profit

$39,430,000,000 (16.30%)

$33,903,000,000 (-16.58%)

$40,640,000,000 (4.87%)

$38,751,000,000 (27.40%)

Operating Income

$9,137,000,000 (-28.38%)

$12,757,000,000 (-29.59%)

$18,117,000,000 (1.08%)

$17,924,000,000 (57.74%)

ABBV Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$20,820,000,000 (-936.34%)

-$2,009,000,000 (-222.47%)

-$623,000,000 (73.42%)

-$2,344,000,000 (93.76%)

Net Cash Flow from Financing

-$5,211,000,000 (69.74%)

-$17,222,000,000 (30.56%)

-$24,803,000,000 (-30.27%)

-$19,039,000,000 (-65.54%)

Net Cash Flow from Operations

$18,806,000,000 (-17.66%)

$22,839,000,000 (-8.44%)

$24,943,000,000 (9.51%)

$22,777,000,000 (29.50%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$7,290,000,000 (-301.77%)

$3,613,000,000 (762.94%)

-$545,000,000 (-142.02%)

$1,297,000,000 (104.12%)

Net Cash Flow - Business Acquisitions and Disposals

-$20,517,000,000 (-1577.60%)

-$1,223,000,000 (-54.03%)

-$794,000,000 (58.25%)

-$1,902,000,000 (95.20%)

Net Cash Flow - Investment Acquisitions and Disposals

$482,000,000 (2290.91%)

-$22,000,000 (-123.91%)

$92,000,000 (538.10%)

-$21,000,000 (-101.43%)

Capital Expenditure

-$974,000,000 (-25.35%)

-$777,000,000 (-11.80%)

-$695,000,000 (11.69%)

-$787,000,000 (1.38%)

Issuance (Repayment) of Debt Securities

$7,251,000,000 (273.18%)

-$4,187,000,000 (66.32%)

-$12,433,000,000 (-47.77%)

-$8,414,000,000 (-211.28%)

Issuance (Purchase) of Equity Shares

-$1,494,000,000 (16.63%)

-$1,792,000,000 (-46.29%)

-$1,225,000,000 (-77.54%)

-$690,000,000 (10.27%)

Payment of Dividends & Other Cash Distributions

-$11,025,000,000 (-4.61%)

-$10,539,000,000 (-4.94%)

-$10,043,000,000 (-8.44%)

-$9,261,000,000 (-20.02%)

Effect of Exchange Rate Changes on Cash

-$65,000,000 (-1400.00%)

$5,000,000 (108.06%)

-$62,000,000 (36.08%)

-$97,000,000 (-1840.00%)

Share Based Compensation

$911,000,000 (21.95%)

$747,000,000 (11.33%)

$671,000,000 (-3.03%)

$692,000,000 (-8.10%)

Depreciation Amortization & Accretion

$8,386,000,000 (-3.59%)

$8,698,000,000 (2.73%)

$8,467,000,000 (-0.63%)

$8,521,000,000 (31.68%)

ABBV Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

70.00% (12.18%)

62.40% (-10.86%)

70.00% (1.45%)

69.00% (3.92%)

Profit Margin

7.60% (-15.56%)

9.00% (-55.88%)

20.40% (-0.49%)

20.50% (102.97%)

EBITDA Margin

25.30% (-17.32%)

30.60% (-25.91%)

41.30% (-2.82%)

42.50% (60.38%)

Return on Average Equity (ROAE)

70.90% (77.25%)

40.00% (-45.80%)

73.80% (-11.72%)

83.60% (61.39%)

Return on Average Assets (ROAA)

3.00% (-16.67%)

3.60% (-57.14%)

8.40% (7.69%)

7.80% (129.41%)

Return on Sales (ROS)

10.40% (-28.77%)

14.60% (-45.32%)

26.70% (-2.20%)

27.30% (120.16%)

Return on Invested Capital (ROIC)

9.10% (-31.06%)

13.20% (-42.36%)

22.90% (15.66%)

19.80% (182.86%)

Dividend Yield

3.50% (-7.89%)

3.80% (8.57%)

3.50% (-7.89%)

3.80% (-13.64%)

Price to Earnings Ratio (P/E)

74.04 (30.43%)

56.77 (133.59%)

24.3 (16.31%)

20.89 (-46.76%)

Price to Sales Ratio (P/S)

5.58 (10.63%)

5.04 (2.31%)

4.93 (15.59%)

4.26 (9.36%)

Price to Book Ratio (P/B)

94.44 (257.60%)

26.41 (59.43%)

16.57 (6.62%)

15.54 (7.39%)

Debt to Equity Ratio (D/E)

39.64 (230.34%)

12 (70.37%)

7.04 (-17.22%)

8.51 (-19.07%)

Earnings Per Share (EPS)

2.4 (-12.09%)

2.73 (-58.95%)

6.65 (2.62%)

6.48 (137.36%)

Sales Per Share (SPS)

31.84 (3.65%)

30.72 (-6.28%)

32.78 (3.24%)

31.75 (15.55%)

Free Cash Flow Per Share (FCFPS)

10.08 (-19.22%)

12.48 (-8.86%)

13.69 (10.21%)

12.42 (23.35%)

Book Value Per Share (BVPS)

1.88 (-67.92%)

5.86 (-39.85%)

9.74 (11.92%)

8.71 (10.98%)

Tangible Assets Book Value Per Share (TABVPS)

22.69 (-14.30%)

26.48 (19.58%)

22.14 (2.59%)

21.58 (4.08%)

Enterprise Value Over EBIT (EV/EBIT)

64 (56.10%)

41 (86.36%)

22 (10.00%)

20 (-57.45%)

Enterprise Value Over EBITDA (EV/EBITDA)

26.51 (37.23%)

19.32 (34.81%)

14.33 (11.16%)

12.89 (-41.67%)

Asset Turnover

0.4 (-1.49%)

0.4 (-1.95%)

0.41 (8.18%)

0.38 (11.80%)

Current Ratio

0.66 (-24.31%)

0.87 (-9.54%)

0.96 (21.41%)

0.79 (-5.81%)

Dividends

$6.2 (4.73%)

$5.92 (4.96%)

$5.64 (8.46%)

$5.2 (10.17%)

Free Cash Flow (FCF)

$17,832,000,000 (-19.17%)

$22,062,000,000 (-9.02%)

$24,248,000,000 (10.27%)

$21,990,000,000 (30.97%)

Enterprise Value (EV)

$377,842,835,397 (17.68%)

$321,064,334,132 (-6.55%)

$343,578,134,898 (11.58%)

$307,910,014,961 (14.75%)

Earnings Before Tax (EBT)

$3,708,000,000 (-40.58%)

$6,240,000,000 (-53.67%)

$13,468,000,000 (3.74%)

$12,982,000,000 (282.72%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$14,254,000,000 (-14.25%)

$16,622,000,000 (-30.68%)

$23,979,000,000 (0.39%)

$23,887,000,000 (96.71%)

Invested Capital

$63,008,000,000 (13.45%)

$55,538,000,000 (-12.87%)

$63,742,000,000 (-8.87%)

$69,943,000,000 (-16.25%)

Working Capital

-$13,167,000,000 (-172.10%)

-$4,839,000,000 (-350.14%)

-$1,075,000,000 (85.21%)

-$7,266,000,000 (-61.90%)

Tangible Asset Value

$40,137,000,000 (-14.25%)

$46,808,000,000 (19.38%)

$39,210,000,000 (2.65%)

$38,199,000,000 (10.51%)

Market Capitalization

$314,020,835,397 (14.77%)

$273,605,334,132 (-4.27%)

$285,804,134,898 (19.40%)

$239,371,014,961 (26.54%)

Average Equity

$6,035,500,000 (-50.32%)

$12,148,500,000 (-24.29%)

$16,046,000,000 (16.20%)

$13,809,250,000 (54.99%)

Average Assets

$142,348,500,000 (5.28%)

$135,210,750,000 (-4.53%)

$141,631,750,000 (-4.60%)

$148,465,000,000 (9.79%)

Invested Capital Average

$64,195,250,000 (7.30%)

$59,829,250,000 (-11.60%)

$67,683,250,000 (-12.91%)

$77,720,000,000 (-4.26%)

Shares

1,767,140,323 (0.09%)

1,765,537,421 (-0.17%)

1,768,480,508 (0.03%)

1,767,880,465 (0.14%)